Stem Cell Research (Jul 2020)

Generation of an induced pluripotent stem cell line (SHCDNi003-A) from a one-year-old Chinese Han infant with Allan–Herndon–Dudley syndrome

  • Anqi Wang,
  • Jiaming Xi,
  • Fang Yuan,
  • Yilin Wang,
  • Simei Wang,
  • Chunmei Wang,
  • Chao Wang,
  • Longlong Lin,
  • Xiaona Luo,
  • Quanmei Xu,
  • Rongrong Yin,
  • Hongyi Cheng,
  • Yuanfeng Zhang,
  • Xiaomin Sun,
  • Jie Yang,
  • Jingbin Yan,
  • Fanyi Zeng,
  • Yucai Chen

Journal volume & issue
Vol. 46
p. 101872

Abstract

Read online

Allan–Herndon–Dudley syndrome (AHDS) is a rare, X-chromosome-linked inherited disorder that affects brain development and is caused by a mutation in SLC16A2. Herein, we generated an induced pluripotent stem cell (iPSC) line from the peripheral blood mononuclear cells of a one-year-old male infant with AHDS using Sendai-virus-mediated reprogramming. These iPSCs exhibited stable amplification, expressed pluripotent markers, and differentiated spontaneously into three germ layers in vitro. Additionally, this iPSC line was found to maintain a normal karyotype and retain the pathogenic mutation in SLC16A2, facilitating the study of disease mechanisms and development of new therapies of AHDS.